Copper-cysteamine and methods of use
US10064942B2 · kind B2 · utility
1Cited by
0References
18Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 31, 2017 |
| Grant date | Sep 4, 2018 |
| Priority date | — |
| Expiry date | Jan 31, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61N2005/109
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Structure and luminescence properties of a new Cu-Cyteamine (Cu-Cy) crystal material are provided. The crystal structure of the Cu-Cy is determined by single crystal X-ray diffraction. It is found that the compound crystallizes in the monoclinic space group C2/c and cell parameters are a=7.5510(4) Å, b=16.9848(7) Å, c=7.8364(4) Å, β=104.798(3)°. The new Cu-Cy crystal material of the invention is also useful for treatment of cancer.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.